The Effects of Physiotherapy in Migraine

ConditionMigraine
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-55
SponsorAnkara Yildirim Beyazıt University

About this trial

The aim of this study is to investigate the effects of a physiotherapy program including cervical muscle training and transcutaneous vagus nerve stimulation on pain, functional status, quality of life, psychological status, and sleep quality in individuals with migraine.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Volunteering to participate in the study

Being between 18 and 55 years of age

Being diagnosed with migraine by a neurologist according to the International Classification of Headache Disorders 3 (ICHD-3) criteria

Disqualifiers

Diagnosis of other primary and/or secondary headaches in addition to migraine,

Coexisting neurological and/or rheumatological diseases,

Severe psychiatric disorders (bipolar disorder, schizophrenia, psychosis, etc.),

Pregnancy or lactation,

Trial design

Design model

Parallel

Treatments tested in this trial

  • Physiotherapy program

    Other intervention

    A physiotherapy program including taVSS and cervical muscle exercises

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: Control GroupNo intervention 0 interventions
Group B: Treatment GroupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Pain Assessment

Individuals' pain parameters will be assessed using a pain diary.

Time frame
Baseline, 8th week (after treatment)

Secondary outcomes

1

Assessment of Functional Status

The Migraine Disability Assessment Scale will be used to determine the functional status associated with migraine. This scale aims to evaluate headache-related disability and the functionality of individuals diagnosed with migraine in daily and social activities.

Time frame
Baseline, 8th week (after treatment)
2

Quality of Life Assessment

The Migraine-Specific Quality of Life Scale (Version 2.1) will be used to assess quality of life.

Time frame
Baseline, 8th week (after treatment)
3

Assessment of Psychological State

The Hospital Anxiety and Depression Scale will be used to assess psychological status.

Time frame
Baseline, 8th week (after treatment)
4

Sleep Quality Assessment

The Single-Item Sleep Quality Scale will be used to assess sleep quality.

Time frame
Baseline, 8th week (after treatment)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: